Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized controlled clinical study of individualized treatment in Helicobacter pylori-associated chronic gastritis
ChiCTR2000038308Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- May 2019
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esomeprazole, furazolidone, amoxicillin, colloidal bismuth pectin, clarithromycin and 1 more in Helicobacter pylori infection and chronic gastritis (3 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Eradication rate of Helicobacter pylori infection. Started May 2019; status: completed.
02
Drugs
esomeprazolefurazolidoneamoxicillincolloidal bismuth pectinclarithromycin
03
Conditions
Helicobacter pylori infectionchronic gastritis
Beyond the preview
Go deeper on ChiCTR2000038308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038308.